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Abstract
Abstract/Background: Dengue is the most important arthropod borne viral disease worldwide in terms of morbidity and
mortality and is caused by any of the four serotypes of dengue virus (DENV-1 to 4). Brazil is responsible for approximately
80% of dengue cases in the Americas, and since the introduction of dengue in 1986, a total of 5,944,270 cases have been
reported including 21,596 dengue hemorrhagic fever and 874 fatal cases. DENV can infect many cell types and cause diverse
clinical and pathological effects. The goal of the study was to investigate the usefulness of NS1 capture tests as an
alternative tool to detect DENV in tissue specimens from previously confirmed dengue fatal cases (n=23) that occurred in
2002 in Brazil.
Methodology/Principal Findings: A total of 74 tissue specimens were available: liver (n=23), lung (n=14), kidney (n=04),
brain (n=10), heart (n=02), skin (n=01), spleen (n=15), thymus (n=03) and lymph nodes (n=02). We evaluated three tests
for NS1 antigen capture: first generation Dengue Early ELISA (PanBio Diagnostics), Platelia NS1 (BioRad Laboratories) and the
rapid test NS1 Ag Strip (BioRad Laboratories). The overall dengue fatal case diagnosis based on the tissues analyzed by
Dengue Early ELISA, Platelia NS1 and the NS1 Ag Strip was 34.7% (08/23), 60.8% (14/23) and 91.3% (21/23), respectively. The
Dengue Early ELISA detected NS1 in 22.9% (17/74) of the specimens analyzed and the Platelia NS1 in 45.9% (34/74). The
highest sensitivity (78.3%; 58/74) was achieved by the NS1 Ag Strip, and the differences in the sensitivities were statistically
significant (p,0.05). The NS1 Ag Strip was the most sensitive in liver (91.3%; 21/23), lung (71.4%; 10/14), kidney (100%; 4/4),
brain (80%; 8/10), spleen (66.6%, 10/15) and thymus (100%, 3/3) when compared to the other two ELISA assays.
Conclusions/Significance: This study shows the DENV NS1 capture assay as a rapid and valuable approach to postmortem
dengue confirmation. With an increasing number of DHF and fatal cases, the availability of new approaches useful for cases
confirmation plays an important tool for the disease surveillance.
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Introduction
Dengue virus (DENV) infection is recognized as one of the most
important mosquito borne human infections in the 21
th century.
The new estimates of the burden of dengue has increased with 2.5
billion people worldwide at risk of contracting the disease, 55% of
world population, and an estimated 70–500 million of dengue
infections occurring annually in 100 endemic countries that
includes approximately 22, 000 fatal cases [1] . Dengue can cause
a mild disease known as dengue fever and more severe and
potentially fatal clinical forms, the Dengue Hemorrhagic Fever
(DHF) and Dengue Shock Syndrome (DSS) [2].
In Brazil, the disease is an important public health problem
associated with explosive epidemics and since DENV introduction
in 1986 [3], a total of 5,944,270 cases were reported including
21,596 DHF and 874 fatal cases.
Currently, laboratorial diagnosis of dengue suspected cases is
based on virus isolation in mosquito cell cultures, detection of viral
RNA and DENV specific antibodies in serum or plasma [4].
However, a number of studies have shown previously that the
DENV nonstructural 1 (NS1) antigen, a highly conserved
glycoprotein produced in both membrane-associated and secreted
forms, is abundant in the serum of patients in the early phase of
infection [5,6,7,8,9] and it is useful in the diagnosis of dengue
infection [8,10,11,12,13] . Furthermore, an evaluation of the three
NS1 tests for early diagnosis of dengue in Brazil was performed
previously [14].
On the other hand, the virological diagnosis in tissues specimens
from dengue fatal cases shows a more complex scenario. The
presence of DENV in frozen and fixed tissues from autopsies can
be determined by viral RNA detection by RT-PCR [15,16] and in
situ hybridization [17], and/or viral proteins detection by
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staining [21] in tissues such as liver, spleen, brain, lung, lymph
node, thymus, kidney, heart, bone marrow and skin. DENV was
previously detected by immunohistochemistry, conventional RT-
PCR and Real-Time RT- PCR in a number of Brazilian human
tissues [22].
Here, we aimed to assess for the first time the usefulness of NS1
capture tests as a diagnostic technique to demonstrate DENV
antigens in human tissue specimens. In this retrospective study was
used tissues homogenates from dengue fatal cases occurred in
Brazil in 2002.
Materials and Methods
Ethics Statement
The specimens analyzed in this study belong to a previously-
gathered collection from the Laboratory of Flavivirus, IOC/
FIOCRUZ from an ongoing Project approved by resolution
number CSN196/96 from the Oswaldo Cruz Foundation Ethical
Committee in Research (CEP 274/05), Ministry of Health, Brazil.
Clinical samples
The human tissues analyzed in this study were obtained from
the collection of the Laboratory of Flavivirus at Oswaldo Cruz
Institute, FIOCRUZ, Brazil, from the epidemic occurred in 2002.
A total of 74 tissue samples were available from 23 fatal cases: liver
(n=23), lung (n=14), kidney (n=04), brain (n=10), heart (n=02),
skin (n=01), spleen (n=15), thymus (n=03) and lymph nodes
(n=02). Tissues sample collections were performed up to 12 hours
(median 6 hours) post-mortem according to the Brazilian Ministry
of Health necropsy protocol recommendations and stored at
270uC until used.
Case confirmation methodology
As a laboratorial routine, all suspected dengue fatal cases are
submitted to all diagnostic methods available in the laboratory to
confirm dengue infection: virus isolation [23,24], RT-PCR [25],
Real Time RT-PCR [26] and also immunohistochemistry when
formalin-fixed [19], paraffin-embedded tissues [19] are available.
Virus isolation
Virus isolation was performed by inoculation into C6/36 Aedes
albopictus cell line [23] and isolates were identified by indirect
fluorescent antibody test (IFAT) using serotype-specific monoclo-
nal antibodies [24].
RT–PCR
RT-PCR for detecting and typing DENV was performed as
described previously [25]. Briefly, consensus primers were used to
anneal to any of the four DENV types and amplify a 511-bp
product in a reverse transcriptase-polymerase reaction. A cDNA
copy of a portion of the viral genome was produced in a reverse
transcriptase reaction. After a second round of amplification
(nested PCR) with type-specific primers, DNA products of unique
sizes for each dengue virus serotype were generated.
Real-time Reverse Transcriptase PCR (TaqMan) assay
One-step real-time RT-PCR assays were performed in the ABI
Prism 7000 Sequence Detection System (SDS) (Applied Biosys-
tems, Foster City, CA) as described previously [26]. Briefly,
samples were assayed in a 30 mL reaction mixture containing the
extracted RNA, 406 Multiscribe enzyme plus RNAse inhibitor,
TaqMan 26 Universal PCR Master Mix (Applied Biosystems,
Foster City, CA) and each specific primer and fluorogenic probe
labeled at the 59 end with 5-carboxyfluorescein (FAM) reporter
dye and at the 39 end with 6-carboxy-N,N,N9,N9-tetramethylrho-
damine (TAMRA) quencher fluorophore. Amplification and real-
time detection consisted of a reverse transcription at 45uC for
30 min followed by one step at 95uC for 10 min and 45 cycles at
95uC for 15 s and 60uC for 1 min.
Immunohistochemistry procedure
The immunohistochemistry procedure was performed as
described previously [19]. Briefly, sections of formalin-fixed,
paraffin-embedded tissues were processed by the avidin biotin
complex (ABC) method according to the manufacturer’s protocol
(Vectastain AEC Kit, Vector Laboratories, Inc. Burlingame, CA,
USA). Monoclonal antibodies for DENV-1, -2, and -3 were
directed against the E protein. Positive and negative controls were
included.
Tissue treatment
Frozen fragments of human tissue (1–2 g) kept at 270uC were
ground and centrifuged as previously described [22]. Briefly, by
using sterile tweezers and scissors a tissue fragment of approxi-
mately 1 cm
3 was cut, transferred and ground by mortar and
pestle procedure in 1.5 ml of Leibovitz-15 medium (Sigma),
pH 7.0–7.4 and 3% sodium penicillin/ streptomycin sulfate. The
ground suspension was transferred to a 15 ml conical tube,
incubated at 4uC for 60 minutes and centrifuged (10,000 rpm at
4uC, for 15 min). The clear supernatant obtained was transferred
to a sterile 2.0 mL cryotube and stored at 270uC until used. The
supernatant used for virus isolation and RNA extraction previously
[22] was used in the present study for all NS1 antigen capture
tests.
Control tissues
Three liver tissues available from cases negative for DENV
infection by using all the methods described above were used as
negative controls. Liver (n=05), lung (n=01), spleen (n=03) and
Author Summary
Dengue manifestations may vary from asymptomatic to
potentially fatal complications. With an increasing number
of Dengue Hemorrhagic fever (DHF) and fatal cases, the
availability of new approaches useful for cases confirma-
tion plays an important role for the disease surveillance.
The diagnosis of fatal cases in frozen and fixed tissues from
autopsies can be determined by techniques such as viral
RT-PCR, in situ hybridization, viral proteins detection by
immunohistochemistry and NS3 specific immunostaining.
We aimed to assess for the first time the usefulness of NS1
capture tests as a diagnostic technique to demonstrate
DENV antigens in human tissue specimens. The highest
sensitivity was obtained by a rapid ICT which was also the
most sensitive in liver, lung, kidney, brain, spleen and
thymus. Despite a number of studies demonstrating the
usefulness of DENV NS1 antigen detection by different
ELISAs in plasma and/or sera of dengue patients, no
research has been done previously to demonstrate NS1
presence in tissues of fatal dengue cases. Moreover, the
application of NS1 kits to demonstrate the presence of
DENV may provide a better understanding of viral tropism
in fatal cases and may be useful for studies of pathogen-
esis in vivo and in experimental animals.
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used to test the cross-reactivity of the NS1 assays. Unfixed frozen
control tissues were prepared and tested in the same manner as for
the dengue positive tissues.
NS1 antigen capture methods
Dengue Early ELISA, first generation (PanBio Diagnos-
tics). The test (Panbio Diagnostics, Brisbane, Austra-
lia) is based on a one-step sandwich format microplate enzyme
immunoassay to detect DENV NS1 antigen. Briefly, the specimens
wereallowedto thawto laboratoryambient temperature(21–22uC).
One hundred microliters of the sample and controls were pipetted
into their respective microwells and incubated for 60 min at 37uC.
After a six-times washing step, 100 mL of HRP conjugate anti-NS1
MAb were pipetted into each well and plate was incubated for
60 min at 37uC. After a six-times washing step, 100 mL of substrate
were pippeted into each well and plate was incubated for 10 min at
room temperature in the dark. The presence of immune-complex
was demonstrated by a color development and the enzymatic
reaction was stopped by adding 100 mLo f1MH 3PO4. The optical
density (OD) reading was taken with a spectrophotometer at a
wavelength of 450–620 nm and the amount of NS1 antigen present
was determined by comparing the OD of the sample tested to the
OD of the cut-off control. Results were calculated as ‘‘Panbio units’’
with results ,9.0, 9.0–11.0, and $11.0 defined as negative,
inconclusive, and positive, respectively. Inconclusive samples were
re-tested to confirm the result.
Platelia Dengue NS1 Ag ELISA (BioRad Laborato-
ries). The test system (Platelia Dengue NS1 Ag ELISA,
BioRad Laboratories, France) is based on a one-step sandwich
format microplate enzyme immunoassay to detect DENV NS1
antigen in human serum or plasma. The test uses murine
monoclonal antibody for capture and revelation. If NS1 antigen
is present in the sample, an immune-complex MAb-NS1-MAb/
peroxidase will be formed. Briefly, the specimens were allowed to
thaw to laboratory ambient temperature (21–22uC). Sample
diluent (50 ml), respective samples and controls (50 ml each) and
100 ml of diluted conjugate were incubated for 90 min at 37uC
within the respective microplate wells coated with purified mouse
anti- NS1 monospecific antibodies. After a six-times washing step,
160 ml of substrate was added into each well and incubated for
30 min at room temperature in the dark. The presence of
immune-complex was demonstrated by a color development and
the enzymatic reaction was stopped by adding 100 mlo f1N
H2SO4. The OD reading was taken with a spectrophotometer at a
wavelength of 450–620 nm and the amount of NS1 antigen
present was determined by comparing the OD of the sample to the
OD of the cut-off control.
Dengue NS1 Ag STRIP (Bio-Rad Laboratories). Dengue
NS1 Ag STRIP (BioRad Laboratories, France) is an
immunochromatographic test (ICT) for the rapid detection of
NS1 antigen. Briefly, one drop of migration buffer was added to
50 mL of sample specimen in a tube and a strip was placed in the
tube. The strip has two lines: a control line (C) (‘biotin – gold
colloidal particles coated with streptavidin’ complex) and a test line
(T) (‘monoclonal anti-NS1 antibodies (mAb) – NS1 Ag – gold
colloidal particles coated with anti-NS1 mAb’ complex). The
appearance of the T and C lines after a migration time of 15
minutes (min) indicates a positive result. The appearance of the C
line alone indicates a negative result. If the C line is not present,
the test is considered invalid and is repeated. It is recommended
that strips giving ambiguous (faint color at the T line) or negative
results are put back in the tube after the initial reading and left for
a further 15 min for re-evaluation.
Statistical analysis
The derived data was tabulated in appropriate worksheets using
the Microsoft Excel programmer and evaluated by chi-square test
using the Epi Info 6 (Center for Disease Control and Prevention,
Atlanta) for any statistical significant association.
Results
Tissues from 23 fatal cases (11 males and 12 females with an age
range of 20–64 y (mean=36 y) were submitted to NS1 antigen
capture tests as a novel approach for dengue fatal case diagnosis.
All cases were submitted to routine diagnosis of fatal dengue
available in the laboratory: virus isolation, RT-PCR, Real Time
RT-PCR and immunohistochemistry when formalin-fixed paraf-
fin-embedded tissues were also available. From our previous
investigation [22], it was shown that DENV-3 could be identified
by virus isolation and/or RT-PCR in 47.8% (11/23) of the cases
and viral RNA could be detected in 91.3% (21/23) of the cases by
Real-time RT-PCR. Viral antigen was detected in 63.1% (12/19)
of the specimens by immunohistochemistry. Fatal case # 9 was
confirmed as dengue case by positive results by Real-time RT-
PCR in CSF and blood, specimens not included in this study
(Table 1).
The overall dengue fatal case confirmation based on the tissues
analyzed by Early ELISA (Panbio), Platelia NS1 (Biorad) and the
NS1 Ag Strip (Biorad) was 34.7% (08/23), 60.8% (14/23) and
91.3% (21/23), respectively (Table 1).
The NS1 antigen capture tests performance according to the
different tissues available is shown on Table 2. The Early ELISA
detected NS1 in 22.9% (17/74) of the tissues specimens analyzed
and the Platelia NS1, 45.9% (34/74). The highest sensitivity
(78.3%; 58/74) was by the NS1 Ag Strip, and the differences in the
sensitivities were statistically significant (p,0.05). The NS1 Ag
Strip was the most sensitive in liver (91.3%, 21/23), lung (71.4%,
10/14), kidney (100%, 4/4), brain (80%, 8/10), spleen (66.6%,
10/15) and thymus (100%, 3/3) when compared to the other two
assays. Lymph node from one case was positive only by the Early
ELISA. The only skin sample in the study was positive by both
Biorad tests.
Table 3 shows the NS1 antigen capture contribution, indepen-
dently of the test used in the different tissues analyzed per case. The
overall sensitivity of this new approach in confirming the fatal cases
was 87.0%. Only fatal case number 19, with only a liver tissue
sample, wasnot confirmed by anyof the NS1 tests used while 22 out
of 23 cases evaluated had at least one positive tissue. In this regard,
there were 17 cases (73.9%) with all tissues examined positive.
In our study, the Early ELISA test (PanBio) was less efficient in
detecting dengue infection in tissues from fatal cases (34.7%)
when compared to the Platelia test (60.8%) and the NS1 Ag Strip
(91.3%). Specificities were 100% for every NS1 antigen capture
tests, based on the three negative tissues for dengue infection in
all diagnostic methods available in the Laboratory. No cross-
reactivity was observed with tissues from fatal cases of yellow
fever.
Discussion
Dengue diagnosis is based on clinical and laboratory findings.
This is of great importance for proper care and treatment of
patients, and guide the implementation of measures aimed at the
control and prevention of outbreaks and epidemics. Currently,
DHF is emerging as an important public health problem in the
world, including in the American region and annually a high
number of cases are reported [1].
Dengue Fatal Diagnosis by NS1 Capture in Tissues
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Case information Case confirmation methods (Araujo et al., 2009)
NS1 antigen capture tests analyzed
(this study)
Fatal
Case Gender Age
Days of
illness
Fresh
tissues
available
Immune
response
(IgG titer)
Virus
Isolation
Serotype
(tissue)
RT-PCR
Serotype
(tissue)
Real-time
RT-PCR
(tissue)
Immuno
Histo
chemistry
(tissue)
Early
ELISA
(tissue)
Platelia
(tissue)
NS1 Ag
STRIP
(tissue)
1 F 62 NA Liver,
lung,
kidney,
brain,
spleen
NA 2 + DENV-3
(liver,
kidney,
brain)
+ (liver,
lung,
brain,
spleen)
22 2+ (liver,
kidney,
brain)
2 M 55 4 Liver,
lung,
brain,
spleen
P( ,40) 22+ (lung,
brain)
2 + (liver,
lung,
brain,
spleen)
2 + (liver,
lung,brain,
spleen)
3 F 39 3 Liver,
skin
P( ,40) 2 + DENV-3
(liver, skin)
2 + (liver) 2 + (liver,
skin)
+ (liver,
skin)
4 M 26 16 Liver,
lung
NA 22+ (liver,
lung)
22 2+ (liver,
lung)
5 F 43 NA Liver,
spleen
NA + DENV-3
(liver)
+ DENV-3
(liver)
+ (liver) NA + (liver) + (liver) + (liver)
6 M 26 NA Liver,
lung,
brain,
thymus,
lymph
nodes
NA 22+ (liver,
lung,
brain)
NA + (liver) 2 + (liver,
lung,brain,
thymus)
7 M NA NA Liver,
lung,
brain,
spleen,
thymus,
lymph
nodes
NA 22+ (liver) NA + (liver,
lung,
spleen,
thymus,
lymph
nodes)
2) +
(liver,brain,
spleen,
thymus)
8 M 49 3 Liver,
lung,
brain,
spleen
NA 22+ (lung) + (liver,
lung,brain,
spleen)
+ (liver,
lung,
spleen)
+ Liver,
lung,
brain,
spleen)
2
9 M 55 6 Liver,
lung
P (1/160) 22222 + (liver,
lung)
+ (liver,
lung)
10 F NA NA Liver,
lung,
spleen
NA 2 + DENV-3
(liver, lung)
+ (liver,
lung)
+ (liver, spleen)+ (lung) + (liver,
lung,
spleen)
+ (liver,
lung,
spleen)
11 M 20 NA Liver,
kidney,
heart,
spleen
NA 2 + DENV-3
(liver,
spleen)
+ (kidney,
heart,
spleen)
+ (kidney) 22 + (liver,
kidney)
12 M 63 NA Liver,
brain,
spleen,
thymus
NA 22+ (liver,
brain)
NA + (brain,
spleen)
2 + (liver,
brain,
spleen,
thymus)
13 F 41 6 Liver,
lung,
brain,
spleen
NA 22+ (spleen) 22 + (liver,
lung,
spleen)
+ (liver,
lung,
spleen)
14 F 38 7 Liver NA 2 + DENV-3
(liver)
+ (liver) + (liver) 2 + (liver) + (liver)
15 F 21 3 Liver,
lung,
brain,
spleen
P( ,40) + DENV-3
(liver)
+ DENV-3
(liver, lung,
brain,
spleen)
+ (liver,
brain,
spleen)
+ (liver,
lung,
spleen)
2 + (liver,
lung,
brain,
spleen)
+ (liver,
lung,
brain,
spleen)
16 M 33 4 Liver,
lung
brain,
spleen
P( ,40) 2 + DENV-3
(lung)
+ (lung,
brain,
spleen)
+ (liver,
brain)
22 + (lung,
brain)
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troublesome because in most of cases only one blood sample is
obtained and the death occurred around defervescence [27] when
positive results of expensive and laborious techniques like viral
isolation and viral RNA detection [15,16,17] might be difficult.
The dengue virological diagnosis in tissues specimens is also
achieved by experiences personnel by immunohistochemistry
[17,18,19,20]. Theses methodologies has allowed the detection
of DENV in liver, spleen, brain, lung, lymph node, thymus,
kidney, heart, bone marrow and skin [15,17,19,20].
Due to cultural and religious beliefs, the lack of anatomic
pathology infrastructure and staff, and biosafety issues, necropsies
might not be usually performed, mainly in incoming countries
[28]. In the present work, three tests for NS1 antigen capture:
Early ELISA test (PanBio), Platelia NS1 (BioRad) and the NS1 Ag
Strip (BioRad) were evaluated in tissues of Brazilian fatal dengue
cases and antigen detection was 34.7% (8/23), 60.8% (14/23) and
91.3% (21/23), respectively. The Early ELISA detected NS1 in
22.9% (17/74) of the samples evaluated and the Platelia NS1 in
45.9% (34/74). The highest sensitivity was obtained by the NS1
Case information Case confirmation methods (Araujo et al., 2009)
NS1 antigen capture tests analyzed
(this study)
Fatal
Case Gender Age
Days of
illness
Fresh
tissues
available
Immune
response
(IgG titer)
Virus
Isolation
Serotype
(tissue)
RT-PCR
Serotype
(tissue)
Real-time
RT-PCR
(tissue)
Immuno
Histo
chemistry
(tissue)
Early
ELISA
(tissue)
Platelia
(tissue)
NS1 Ag
STRIP
(tissue)
17 F 51 NA Liver,
spleen
P( ,40) 22+ (liver,
spleen)
+ (liver,
spleen)
+ (liver) + (liver,
spleen)
+ (liver,
spleen)
18 F 38 7 Liver NA 22+ (liver) + (liver) 2 + (liver) + (liver)
19 F 30 NA Liver P (,40) 22+ (liver) + (liver) 22 2
20 F 42 NA Liver,
lung,
kidney,
heart,
spleen
NA 2 + DENV-3
(liver,
lung,,
heart,
spleen)
+ (liver,
lung,
kidney,
spleen)
NA + (heart) + (liver,
lung,
kidney,
heart,
spleen)
+ (liver,
lung,
kidney,
heart,
spleen)
21 M 51 NA Liver NA 2 + DENV-3
(liver)
222 + (liver) + (liver)
22 M 64 NA Liver,
spleen
NA 22+ (liver,
spleen)
+ (liver) 2 + (liver,
spleen)
+ (liver,
spleen)
23 F NA NA Liver,lung,
kidney,
brain,
spleen
NA 2 + DENV-3
(liver, lung,
kidney,
brain)
+ (liver,
kidney)
2 + (lung) + (liver,
lung,
kidney,
brain,
spleen)
+ (liver,
lung,
kidney,
brain,
spleen)
Total* 2/23 (8.6) 11/23 (47.8) 20/23 (86.9) 11/19 (57.8) 8/23 (34.7) 14/23 (60.8) 21/23
(91.3)
doi:10.1371/journal.pntd.0001147.t001
Table 1. Cont.
Table 2. NS1 antigen capture tests applied to tissues (n=74) from confirmed dengue fatal cases (n=23).
Tissues analyzed Confirmation methods (Araujo et al., 2009) Positive/Tested (%)
NS1 antigen capture tests analyzed (this study)
Positive/Tested (%)
Virus isolation RT-PCR
Real-time
RT-PCR
Immuno Histo
Chemistry Early ELISA Platelia NS1 Ag STRIP
Liver (n=23) 2/22 (9) 10/23 (43.4) 16/23 (69.5) 12/17 (70.5) 6/23 (26) 14/23 (60.8) 21/23 (91.3)
Lung (n=14) 0/14 5/14 (35.7) 8/14 (57.1) 3/10 (30) 4/14 (28.5) 5/14 (35.7) 10/14 (71.4)
Kidney (n=04) 0/4 2/4 (50) 3/4 (75) 1/2 (50) 0/4 2/4 (50) 4/4 (100)
Brain (n=10) 0/10 3/10 (30.0) 6/10 (60.0) 2/6 (33.3) 2/10 (20.0) 3/10 (30) 8/10 (80.0)
Heart (n=02) 0/2 K (50) K (50) 0/1 0/2 K (50) K (50)
Skin (n=01) ND 1/1 (100) ND 0/1 0/1 1/1 (100) 1/1 (100)
Spleen (n=15) 0/14 3/14 (21.4) 8/15 (53.3) 5/10 (50) 3/15 (20) 8/15 (53.3) 10/15 (66.6)
Thymus (n=03) 0/3 0/3 0/3 NA 1/3 (33.3) 0/3 3/3 (100)
Lymph nodes (n=02) 0/2 0/2 0/2 NA 1/2 (50) 0/2 0/2
Total (n=74) 2/71 (2.8) 25/73 (34.2) 42/73 (57.5) 23/47 (48.9) 17/74 (22.9) 34/74 (45.9) 58/74 (78.3)
*Total positive /total tested (%), ND: not done, NA: not available.
doi:10.1371/journal.pntd.0001147.t002
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significant (p,0,05). Among the ELISA assays studied, the NS1 Ag
Strip was the most sensitive in liver, lung, kidney, brain, spleen and
thymus. Despite those results, we are not able to infer whether or
not this detection was due to in situ viral replication or may be due
to the virus present in the blood supporting these tissues.
Only the Real Time RT-PCR technique [22] performed in the
evaluated tissues was more sensitive than the NS1 Ag Strip assay.
The sensitivities of any of the three NS1 capture assays were
higher than the viral isolation and conventional RT-PCR.
Despite a number of prior studies have demonstrated the
usefulness of DENV NS1 antigen detection by different ELISA
assays in plasma and/or sera of dengue patients [8,10,11,12,13,14],
no research has been done previously to demonstrate NS1 presence
in tissues of fatal dengue. However, in the present work the NS1
antigen was detected in 22 out of 23 dengue fatal cases examined and
73.9% of all tissues specimens evaluated were positive. Most tissues
included in this study, liver, lung, kidney, brain, skin, and spleen have
been reported with DENV presence in previous studies using
molecular and immunohistochemical methods [15,17,19,20,29].
However, we demonstrated here NS1 in heart and thymus tissue
while so far not cardiac tissue has been reported with DENV antigen
and/or viral RNA and thymus tissue with DENV RNA has been
demonstrated once [30].
The liver was recognized as a major target organ in the
pathogenesis of DENV infection, its active hepatocyte replication
perhaps accounting for these findings [31,32]. Furthermore, our
findings suggest the liver as the most appropriate tissue for NS1
antigen detection. The breakdown of the blood-brain barrier has
been shown previously in fatal dengue cases [19]. In a study of 378
Vietnamese patients with suspected central nervous system
infections, 4.2% were infected with DENV [33]. Furthermore,
DENV infection could involve the heart and cause cardiac
dysfunction, however, lesions in the heart have not been well
documented, nevertheless, flame-shaped subendocardial haemor-
rhage in the left-ventricular septum has been reported [34],
cardiac rhythm disorders, such as atrioventricular block [35,36]
and ectopic ventricular beats [37], have been described during
episodes of DHF, most of them presenting a benign course with
spontaneous resolution. These clinical features have been
attributed to viral myocarditis; however the exact mechanism
has yet to be elucidated definitively.
Besides common manifestations of dengue infection, thoracic
manifestations such as pleural effusion and pneumonitis are
described in DHF. Morphological studies of lung tissues revealed
interstitial pneumonia associated with focal or diffuse zones of
alveolar congestion and hemorrhage, increase of alveolar macro-
phages number, recruiting of platelets, mononuclear and poly-
Table 3. Dengue fatal case confirmation by any of the NS1 capture tests per tissues per case.
Fatal
Case #
Liver
(n=23)
Lung
(n=14)
Kidney
(n=4)
Brain
(n=10)
Heart
(n=2)
Skin
(n=1)
Spleen
(n=15)
Thymus
(n=3)
Lymph
nodes
(n=2)
Positive by any NS1
capture test / tissues
available per case
1 + 2 ++ NA NA 2 NA NA 3/5 (60)
2 ++NA + NA NA + NA NA 4/4 (100)
3 + NA NA NA NA + NA NA NA 2/2 (100)
4 ++NA NA NA NA NA NA NA 2/2 (100)
5 + NA NA NA NA NA 2 NA NA 1/2 (50)
6 ++NA + NA NA NA + 2 4/5(80)
7 ++NA + NA NA ++ + 6/6 (100)
8 ++NA + NA NA + NA NA 4/4 (100)
9 ++NA NA NA NA NA NA NA 2/2 (100)
10 ++NA NA NA NA + NA NA 3/3 (100)
11 + NA + NA 2 NA 2 NA NA 2/4 (50)
12 + NA NA + NA NA ++ NA 4/4 (100)
13 ++NA 2 NA NA + NA NA 3/4 (75)
14 + NA NA NA NA NA NA NA NA 1/1 (100)
15 ++NA + NA NA + NA NA 4/4 (100)
16 2 + NA + NA NA 2 NA NA 2/4 (50)
17 + NA NA NA NA NA + NA NA 2/2 (100)
18 + NA NA NA NA NA NA NA NA 1/1 (100)
19 2 NA NA NA NA NA NA NA NA 0/1
20 +++ NA + NA + NA NA 5/5 (100)
21 + NA NA NA NA NA NA NA NA 1/1 (100)
22 + NA NA NA NA NA + NA NA 2/2 (100)
23 +++ + NA NA + NA NA 5/5 (100)
Total* 21/23 (91.3) 12/13 (92.3) 4/4 (100) 9/10 (90.0) 1/2 (50) 1/1 (100) 11/15 (73.3) 3/3 (100) 1/2 (50) 63/75 (84)
*Positive/total analyzed (%), +: positive sample, 2: negative sample, NA: not available.
doi:10.1371/journal.pntd.0001147.t003
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in inflammatory cells of the lung and spleen [39].
The application of NS1 antigen capture kits to demonstrate the
presence of DENV may provide a better understanding of viral
tropism in fatal cases and may be useful for studies of pathogenesis
in vivo and in experimental animals. Moreover, NS1 capture
ELISAs and ICTs, are rapid, inexpensive and require less
laboratory expertise than the molecular and immunohistochemical
techniques currently used to detect DENV in tissues.
In fact, the ELISA alternative to confirm DENV infection in
suspected dengue fatal cases may be very beneficial in low
resources settings facing necropsies rejection due to the small piece
of tissue (1–2 g) needed to perform the technique which can be
easily obtained via needle biopsy. The needle biopsy has been
already proven as a helpful procedure in low resources settings
[28] and in dengue studies [17,40,41].
The detection of viral antigens in tissues by ELISA has been
reported previously in animals, in the European brown hare
syndrome virus in hares’s splenic tissues [42], West Nile virus
antigen in avian tissues [43] and Ebola virus antigen in the spleen
and liver tissues from monkeys [44]. Nevertheless, in this report is
demonstrated DENV antigen in a number of different human
tissues.
In our study, even though we are not able to confirm whether
the NS1 antigen captured was from the tissues cells or the
circulating blood irrigating those, we aimed here to stress the role
of this approach as an alternative tool. However, the presence of
DENV antigen in some tissues by immunohistochemistry could
infer the presence of NS1 within those tissues. Further immuno-
staining studies on those tissues by using anti-NS1 antibodies, for
instance are suggested to help elucidate those issues. Furthermore,
as few negative control samples of tissues other than liver were
tested using the NS1 assays, further studies to establish the
specificity of this approach are needed before NS1 antigen testing
can be relied upon for the diagnosis of fatal dengue.
In summary, even though the lack of common tissues and
consistent testing for each tissue for each case may not be the best
assessment for this approach, this study demonstrates that DENV
NS1 capture assays are a valuable approach to postmortem
dengue confirmation and may be used as a clinical/pathological
diagnostic tool. To the best of our knowledge, this is the first time
an ELISA and an ICT for detecting DENV antigens in tissues is
evaluated. The accuracy, sensitivity and rapidity of the NS1 Ag
Strip make it suitable for effective dengue surveillance and indicate
its use as a complement for the diagnosis of fatal dengue cases.
This evaluation was performed for research purposes only and
authors have no financial interest.
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